CAMBRIDGE, MA, Biotechnology company focused on designing highly selective and potent medicines to disrupt known drivers of serious diseases, has raised a $43 million Series B round. Read More
NEW YORK, NY, Leading provider of real-time engagement solutions for mobile and web platforms, today announced that Intel Capital has made an undisclosed investment in the company. Read More
CHESTNUT HILL, MA, Leader in men's health research and development, announced the completion of a $1.1 million seed financing round from Romulus Capital. Read More
